The combination of Gliclazide and Metformin can be an effective multifunctional way to increase insulin secretion and reduce blood sugar concentrations. Consult with your doctor to find out if Gliza MF can help alleviate your symptoms safely and effectively.
Gliclazide increases insulin secretion and Metformin improves insulin sensitivity also reduces glucose production in the liver thus provides dual benefits because of the complimentary action.
Indication: NIDDM patients not controlled with monotherapy in obese patients.
Drug Composition: 80 mg Gliclazide and 500 mg Metformin per tablet.
Dosage: 1 tablet B.D.
Contraindications: Hypersensitivity; Type 1 Diabetes Mallitus; Severe Renal and hepatic impairment; diabetic coma, diabetic ketoacidosis; cardiac failure.
Precautions: Hypoglycaemia. May require insulins during metabolic stress.
This product is currently only available in India against valid prescription from a Registered Medical Practitioner. This is not an offer for sale.